4.7 Article

Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: Post-hoc analysis of concomitant add-on versus sequential add-on to metformin and of triple versus dual therapy with metformin

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes

Cristina Bianchi et al.

Article Endocrinology & Metabolism

One-year efficacy and safety of saxagliptin add-on in patients receiving dapagliflozin and metformin

S. Matthaei et al.

DIABETES OBESITY & METABOLISM (2016)

Review Biochemistry & Molecular Biology

DPP-4 inhibitor plus SGLT-2 inhibitor as combination therapy for type 2 diabetes: from rationale to clinical aspects

Andre J. Scheen

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)

Article Endocrinology & Metabolism

Safety of saxagliptin: events of special interest in 9156 patients with type 2 diabetes mellitus

Boaz Hirshberg et al.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2014)

Article Public, Environmental & Occupational Health

Safety Profile of Dapagliflozin for Type 2 Diabetes: Pooled Analysis of Clinical Studies for Overall Safety and Rare Events

Agata Ptaszynska et al.

DRUG SAFETY (2014)

Article Endocrinology & Metabolism

Urinary tract infections in patients with diabetes treated with dapagliflozin

Kristina M. Johnsson et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2013)

Article Endocrinology & Metabolism

Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin

Kristina M. Johnsson et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2013)